Ma. Weis et al., STRUCTURALLY ABNORMAL TYPE-II COLLAGEN IN A SEVERE FORM OF KNIEST DYSPLASIA CAUSED BY AN EXON-24 SKIPPING MUTATION, The Journal of biological chemistry, 273(8), 1998, pp. 4761-4768
Type II collagen mutations have been identified in a phenotypic contin
uum of chondrodysplasias that range widely in clinical severity. They
include achondrogenesis type II, hypochondrogenesis, spondyloepiphysea
l dysplasia congenita, spondyloepimetaphyseal dysplasia, Kniest dyspla
sia, and Stickler syndrome. We report here results that define the und
erlying genetic defect and consequent altered structure of assembled t
ype II collagen in a neonatal lethal form of Kniest dysplasia, Electro
phoresis of a cyanogen bromide (CNBr) (CB) digest of sternal cartilage
revealed an alpha 1(II)CB11 peptide doublet and a slightly retarded m
obility for all major CB peptides, which implied post-translational ov
ermodification. Further peptide mapping and sequence analysis of CB11
revealed equal amounts of a normal alpha 1(II) sequence and a chain la
cking the 18 residues (361-378 of the triple helical domain) correspon
ding to exon 24. Sequence analysis of an amplified genomic DNA fragmen
t identified a G to A transition in the +5 position of the splice dono
r consensus sequence of intron 24 in one allele. Cartilage matrix anal
ysis showed that the short alpha 1(II) chain was present in collagen m
olecules that had become cross-linked into fibrils. Trypsin digestion
of the pepsin-extracted native type II collagen selectively cleaved th
e normal length alpha 1(II) chains within the exon 24 domain, These fi
ndings support a hypothesis that normal and short alpha-chains had com
bined to form hetero trimeric molecules in which the chains were in re
gister in both directions from the deletion site, accommodated effecti
vely by a loop out of the normal chain exon 24 domain. Such an accommo
dation, with potential overall shortening of the helical domain and he
nce misalignment of intermolecular relationships within fibrils, offer
s a common molecular mechanism by which a group of different mutations
might act to produce the Kniest phenotype.